Jun 10, 2024, 16:08
It was great to catch up with Mazyar Shadman at ASCO24 – VJHemOnc
VJHemOnc shared a post on X:
“It was great to catch up with Mazyar Shadman at ASCO24 to find out if BTK inhibitors are a suitable treatment option for patients with CLL and cardiovascular comorbidities.
Click here to watch.”
Source: VJHemOnc/X
Jun 29, 2024, 23:21